Human recombinant erythropoietin and the incidence of retinopathy of prematurity: A multiple regression model

Journal of AAPOS

Volumn 12, Issue 3, 2008, Pages 233-238

  Suk, Kevin K ^a   Dunbar, Jennifer A ^a   Liu, Anthony ^a   Daher, Noha S ^a   Leng, Cheri K ^b   Leng, Jason K ^a   Lim, Pauline ^b   Weller, Samantha ^c   Fayard, Elba ^a  

^a LOMA LINDA UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; IRON; RECOMBINANT ERYTHROPOIETIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; DISEASE SEVERITY; DRUG DOSE COMPARISON; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; INCIDENCE; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN ANEMIA; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; REPEATED DRUG DOSE; RETROLENTAL FIBROPLASIA; RISK FACTOR; SEPSIS; STATISTICAL MODEL;

AGE FACTORS; ANEMIA, NEONATAL; BIRTH WEIGHT; CALIFORNIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN, RECOMBINANT; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT, NEWBORN; MODELS, STATISTICAL; PROGNOSIS; REGRESSION ANALYSIS; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 45449114982     PISSN: 10918531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaapos.2007.08.009     Document Type: Article

References (47)

1. Rudanko S.L., Fellman V., and Laatikainen L. Visual impairment in children born prematurely from 1972 through 1989. Ophthalmology 110 (2003) 1639-1645
2. Gilbert C., and Foster A. Childhood blindness in the context of VISION 2020-The Right to Sight. Bull World Heath Organ 79 (2001) 227-232
3. Steinkuller P.G., Du L., Gilbert C., Foster A., Collins M.L., and Coats D.K. Childhood blindness. J AAPOS 3 (1999) 26-32
4. Valentine P.H., Jackson J.C., Kalina R.E., and Woodrum D.E. Increased survival of low birth weight infants: Impact on the incidence of retinopathy of prematurity. Pediatrics 84 (1989) 442-445
5. Larsson E., Carle-Petrelius B., Cernerud G., Ots L., Wallin A., and Holmström G. Incidence of ROP in two consecutive Swedish population based studies. Br J Ophthalmol 86 (2002) 1122-1126
6. Termote J., Schalij-Delfos N.E., Donders A.R.T., and Cats B.P. The incidence of visually impaired children with retinopathy of prematurity and their concomitant disabilities. J AAPOS 7 (2003) 131-136
7. O'Shea T.M., Klinepeter K.L., Goldstein D.J., Jackson B.W., and Dillard R.G. Survival and developmental disability in infants with birth weights of 501 to 800 grams born between 1979 and 1994. Pediatrics 100 (1997) 982-986
8. Hameed B., Shyamanur K., Kotecha S., Metz H.S., Flynn J.T., Tung B., and Hardy R.J. Trends in the incidence of severe retinopathy of prematurity in a geographically defined population over a 10-year period. Pediatrics 113 (2004) 1653-1657
9. Todd D.A., Kennedy J., Cassell C., Roberts S., and John E. Retinopathy of prematurity in infants <29 weeks' gestation at birth in New South Wales from 1986-92. J Paediatr Child Health 34 (1998) 32-36
10. Palmer E.A., Flynn J.T., Hardy R.J., Phelps D.H., Phillips C.L., Schaffer D.B., and Tung B. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 98 (1991) 1628-1640
11. Schaffer D.B., Palmer E.A., Plotsky D.F., Manktelow B.N., Woodruff G., Draper E.S., Field D., and Cryotherapy for Retinopathy of Prematurity Cooperative Group. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 100 (1993) 230-237
12. Wheatley C.M., Dickinson J.L., Mackey D.A., Craig J.E., and Sale M.M. Retinopathy of prematurity: Recent advances in our understanding. Arch Dis Child Fetal Neonatal Ed 87 (2002) F78-F82
13. Allegaert K., de Coen K., Devlieger H., and EpiBel Study Group. Threshold retinopathy at threshold of viability: The EpiBel study. Br J Ophthalmol 88 (2004) 239-242
14. Shohat M., Reisner S.H., Krikler R., Nissenkorn I., Yassur Y., and Ben-Sira I. Retinopathy of prematurity: Incidence and risk factors. Pediatrics 72 (1983) 159-163
15. Goldberg M.A., and Schneider T.J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269 (1994) 4355-4359
16. Heeschen C., Aicher A., Lehmann R., et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102 (2003) 1340-1346
17. Ribatti D., Presta M., Vacca A., et al. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93 (1999) 2627-2636
18. Fisher J.W. Erythropoietin: Physiology and pharmacology update. Exp Biol Med 228 (2003) 1-14
19. Jaquet K., Krause K., Tawakol-Khodai M., Geidel S., and Kuck K.H. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 64 (2002) 326-333
20. Carlini R.G., Reyes A.A., and Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int 47 (1995) 740-745
21. Pierce E.A., Foley E.D., and Smith L.E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 114 (1996) 1219-1228
22. Smith L.E. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res 14 (2004) S140-S144
23. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: Preliminary results. Arch Ophthalmol 106 (1988) 471-479
24. Maier R.F., Obladen M., Scigalla P., Linder Kamp O., Duc G., Hieronimi G., et al., European Multicentre Erythropoietin Study Group. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. N Engl J Med 330 (1994) 1173-1178
25. Meyer M.P., Meyer J.H., Commerford A., Hann F.M., Sive A.A., Molter G., et al. Recombinant human erythropoietin in the treatment of the anemia of prematurity: Results of a double-blind, placebo-controlled study. Pediatrics 93 (1994) 918-923
26. Vamvakas E.C., and Strauss R.G. Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion 41 (2001) 406-415
27. Maier R.F., Obladen M., Müller-Hansen I., Kattner E., Merz U., Arlettaz R., et al., European Multicenter Erythropoietin Beta Study Group. Early treatment with erythropoietin β ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000g. J Pediatr 141 (2002) 8-15
28. Ohls R.K., Harcum J., Schibler K.R., and Christensen R.D. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled study. J Pediatr 131 (1997) 661-665
29. Carlini R.G., Dusso A.S., Obialo C.I., Alvarez U.M., and Rothstein M. Recombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells. Kidney Int 43 (1993) 1010-1014
30. Akimoto T., Kusano E., Inaba T., Iimura O., Takahashi H., Ikeda H., et al. Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway. Kidney Int 58 (2000) 269-282
31. Wang G.L., and Semenza G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90 (1993) 4304-4308
32. Juul S.E., Yachnis A.T., and Christensen R.D. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 52 (1998) 235-249
33. Junk A.K., Mammis A., Savitz S.I., Singh M., Roth S., Malhotra S., et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 99 (2002) 10659-10664
34. Seiberth V., and Linderkamp O. Risk factors in retinopathy of prematurity: A multivariate statistical analysis. Ophthalmologica 214 (2000) 131-135
35. Darlow B.A., Horwood L.J., and Clemett R.S. Retinopathy of prematurity: Risk factors in a prospective population-based study. Paediatr Perinat Epidemiol 6 (1992) 62-80
36. Hardy R.J., Palmer E.A., Dobson V., Summers C.G., Phelps D.L., Quinn G.E., et al., Cryotherapy for Retinopathy of Prematurity Cooperative Group. Risk analysis of prethreshold retinopathy of prematurity. Arch Ophthalmol 121 (2003) 1697-1701
37. Early Treatment For Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: Results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 121 (2003) 1684-1694
38. Hirano K., Morinobu T., Kim H., Hiroi M., Ban R., Ogawa S., et al. Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants. Arch Dis Child Fetal Neonatal Ed 84 (2001) F188-F193
39. Dani C., Reali M.F., Bertini G., Martelli E., Pezzati M., and Rubaltelli F.F. The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev 62 (2001) 57-63
40. Hesse L., Eberl W., Schlaud M., and Poets C.F. Blood transfusion. Iron load and retinopathy of prematurity. Eur J Pediatr 156 (1997) 465-470
41. Cooke R.W., Clark D., Hickey-Dwyer M., and Weindling A.M. The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatr 152 (1993) 833-836
42. DiBiasie A. Evidence-based review of retinopathy of prematurity prevention in VLBW and ELBW infants. Neonatal Network 25 (2006) 393-403
43. Akkoyun I., Oto S., Yilmaz G., Gurakan B., Tarcan A., Anuk D., et al. Risk factors in the development of mild and severe retinopathy of prematurity. JAAPOS 10 (2006) 449-453
44. Romagnoli C., Zecca E., Gallini F., Girlando P., and Zuppa A.A. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?. Eur J Pediatr 159 (2000) 627-634
45. Brown M.S., Baron A.E., France E.K., and Hamman R.F. Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity. J AAPOS 10 (2006) 143-149
46. Lucey J.F., Rowan C.A., Shiono P., et al. Fetal infants: The fate of 4172 infants with birth weights of 401 to 500 grams-the Vermont Oxford Network experience (1996-2000). Pediatrics 113 (2004) 1559-1566
47. Palmer E.A., Hardy R.J., Dobson V., Phelps D.L., Quinn G.E., Summers C.G., Krom C.P., Tung B., and Cryotherapy for Retinopathy of Prematurity Cooperative Group. 15-year outcomes following threshold retinopathy of prematurity: Final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 123 (2005) 311-318